CymaBay Therapeutics Competitors and Similar CompaniesClear all
CymaBay Therapeutics's competitors and similar companies include Livzon Pharmaceutical Group, Cadila Pharmaceuticals, Alembic Pharmaceuticals and UCB.
 CymaBay Therapeutics CymaBay Therapeutics is a clinical-stage biopharmaceutical company developing therapies for metabolic and rare diseases. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1991 | Founding Date 1985 | Founding Date 1951 | Founding Date 2010 | Founding Date 1928 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Newark, US HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | |
Employees | Employees 387% decrease | Employees 9,067 | Employees 8,5201% increase | Employees 14,858 | Employees 9,052 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $31.1m (FY, 2023) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A | Cost of goods ₹19.8b (FY, 2026) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit N/A | Gross profit ₹54.1b (FY, 2026) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($105.4m) (FY, 2023) | Net income ¥2.4b (FY, 2025) | Net income N/A | Net income ₹6.7b (FY, 2026) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company